LH vs UHS
Labcorp Holdings Inc. and Universal Health Services, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | LH | UHS |
|---|---|---|
| Revenue | $14.0B | $17.4B |
| Net income | $876.5M | $1.5B |
| Gross margin | 28.8% | — |
| Net margin | 6.3% | 8.6% |
| Return on equity | 10.5% | 21.4% |
| Diluted EPS | $10.46 | — |
| Dividend / share | $2.88 | $0.80 |
| Payout ratio | 27.5% | 3.4% |
| Free cash flow | $1.2B | $849.2M |
| Equity | $8.6B | $7.3B |
| Net debt / equity | 0.59× | 0.63× |
| Current ratio | 1.42× | 1.05× |
| Revenue CAGR 5y | −0.0% | 8.5% |
| Profit CAGR 5y | −10.8% | 9.5% |
UHS bills 1.2× the revenue of LH, and keeps more of each dollar of revenue as profit (8.6% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | LH | UHS |
|---|---|---|
| FY2025 | $14.0B | $17.4B |
| FY2024 | $13.0B | $15.8B |
| FY2023 | $12.2B | $14.3B |
| FY2022 | $11.9B | $13.4B |
| FY2021 | $13.1B | $12.6B |
| FY2020 | $14.0B | $11.6B |
| FY2019 | $11.6B | $11.4B |
| FY2018 | $11.3B | $10.8B |
| FY2017 | $10.3B | $10.4B |
| FY2016 | $9.6B | $9.8B |
Net income by year
Bottom line
| Fiscal year | LH | UHS |
|---|---|---|
| FY2025 | $876.5M | $1.5B |
| FY2024 | $746.0M | $1.1B |
| FY2023 | $418.0M | $717.8M |
| FY2022 | $1.3B | $675.6M |
| FY2021 | $2.4B | $991.6M |
| FY2020 | $1.6B | $944.0M |
| FY2019 | $823.8M | $814.9M |
| FY2018 | $883.7M | $779.7M |
| FY2017 | $1.2B | $752.3M |
| FY2016 | $711.8M | $702.4M |
Advertisement
AdSense · Rectangle 336×280